- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 59.5M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $32.74M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $27.47M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $24.91M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $24.27M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $53.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $54.26M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $109.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $113.21M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $164.23M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $174.35M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 61.5M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.65M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $165.31M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $173.4M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.91M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.84M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$9.43M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $12.36M |
| Revenue | Q1 2025 · Mar 31, 2024 | $47.89M |